Clinical Trials Browser

Phase 1 × bicalutamide × 90 days × Clear all

NCT05521698 2026-06-04

A Randomized Trial of Bicalutamide in Non-Muscle Invasive Bladder Cancer

Phase 1 Recruiting

Non-Muscle Invasive Bladder Urothelial Carcinoma